AU2011275458B2 - Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster - Google Patents

Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster Download PDF

Info

Publication number
AU2011275458B2
AU2011275458B2 AU2011275458A AU2011275458A AU2011275458B2 AU 2011275458 B2 AU2011275458 B2 AU 2011275458B2 AU 2011275458 A AU2011275458 A AU 2011275458A AU 2011275458 A AU2011275458 A AU 2011275458A AU 2011275458 B2 AU2011275458 B2 AU 2011275458B2
Authority
AU
Australia
Prior art keywords
peg
polyethylene glycol
relapse
herpes
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011275458A
Other languages
English (en)
Other versions
AU2011275458A1 (en
Inventor
Marcel Langenauer
Paul Martin Scherer
Peter Vitins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devirex AG
Original Assignee
Devirex AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex AG filed Critical Devirex AG
Publication of AU2011275458A1 publication Critical patent/AU2011275458A1/en
Application granted granted Critical
Publication of AU2011275458B2 publication Critical patent/AU2011275458B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011275458A 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster Ceased AU2011275458B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (2)

Publication Number Publication Date
AU2011275458A1 AU2011275458A1 (en) 2013-02-28
AU2011275458B2 true AU2011275458B2 (en) 2014-11-27

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011275458A Ceased AU2011275458B2 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Country Status (20)

Country Link
US (2) US9814743B2 (cg-RX-API-DMAC10.html)
EP (1) EP2563374B1 (cg-RX-API-DMAC10.html)
JP (1) JP5858994B2 (cg-RX-API-DMAC10.html)
KR (1) KR101881175B1 (cg-RX-API-DMAC10.html)
CN (1) CN103079574B (cg-RX-API-DMAC10.html)
AU (1) AU2011275458B2 (cg-RX-API-DMAC10.html)
CA (1) CA2803228C (cg-RX-API-DMAC10.html)
DK (1) DK2563374T3 (cg-RX-API-DMAC10.html)
ES (1) ES2442928T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20140135T1 (cg-RX-API-DMAC10.html)
IL (1) IL223582A (cg-RX-API-DMAC10.html)
MX (1) MX2012014783A (cg-RX-API-DMAC10.html)
PL (1) PL2563374T3 (cg-RX-API-DMAC10.html)
PT (1) PT2563374E (cg-RX-API-DMAC10.html)
RS (1) RS53162B (cg-RX-API-DMAC10.html)
RU (1) RU2643763C2 (cg-RX-API-DMAC10.html)
SG (1) SG186937A1 (cg-RX-API-DMAC10.html)
SI (1) SI2563374T1 (cg-RX-API-DMAC10.html)
WO (1) WO2012004669A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201300177B (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012004669A1 (en) 2010-07-08 2012-01-12 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
CA2899424A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
TW201825095A (zh) * 2016-11-28 2018-07-16 德商艾庫里斯抗感染治療有限公司 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物
AU2020268896B2 (en) 2019-05-03 2024-11-28 F. Hoffmann-La Roche Ag Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
AU2021208515A1 (en) 2020-01-15 2022-08-04 F. Hoffmann-La Roche Ag Methods to decrease impurities from recombinant protein manufacturing processes
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087161A2 (en) * 1982-02-24 1983-08-31 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
RU2009127890A (ru) 2007-01-17 2011-02-27 Девирэкс Аг (Ch) Составы, содержащие циклодекстрины
WO2012004669A1 (en) 2010-07-08 2012-01-12 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087161A2 (en) * 1982-02-24 1983-08-31 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COREY L. et al, A TRIAL OF TOPICAL ACYCLOVIR IN GENITAL HERPES SIMPLEX VIRUS INFECTIONS, 1982, New England Journal of Medicine, Vol. 306(22), Pg. 1313-1319 *

Also Published As

Publication number Publication date
JP5858994B2 (ja) 2016-02-10
ES2442928T3 (es) 2014-02-14
JP2013530208A (ja) 2013-07-25
US9814743B2 (en) 2017-11-14
RU2643763C2 (ru) 2018-02-05
EP2563374B1 (en) 2013-11-13
AU2011275458A1 (en) 2013-02-28
KR101881175B1 (ko) 2018-07-23
CN103079574A (zh) 2013-05-01
US20130090389A1 (en) 2013-04-11
IL223582A (en) 2017-12-31
US20180055875A1 (en) 2018-03-01
ZA201300177B (en) 2014-03-26
CA2803228A1 (en) 2012-01-12
CA2803228C (en) 2019-03-12
SG186937A1 (en) 2013-02-28
MX2012014783A (es) 2013-04-03
PL2563374T3 (pl) 2014-04-30
RS53162B (sr) 2014-06-30
HRP20140135T1 (hr) 2014-03-28
DK2563374T3 (da) 2014-01-20
KR20130142992A (ko) 2013-12-30
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
HK1180969A1 (en) 2013-11-01
CN103079574B (zh) 2017-04-12
EP2563374A1 (en) 2013-03-06
PT2563374E (pt) 2014-01-23
SI2563374T1 (sl) 2014-01-31

Similar Documents

Publication Publication Date Title
CA2803228C (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US20100111883A1 (en) Cyclodextrin formulations
AU707353B2 (en) Bioadhesive-wound healing composition
JP2025109935A (ja) カンナビジオールを含む局所製剤、組成物の調整方法およびその方法
Stoopler et al. Topical and systemic therapies for oral and perioral herpes simplex virus infections
US9144576B2 (en) Topical antiviral formulations
WO2007084179A1 (en) Skin treatment educational kit
JP2002538200A (ja) 長鎖炭化水素およびヌクレオシド類似体によるウイルス複製の相乗的阻害
Raborn et al. Oral acyclovir in prevention of herpes labialis: a randomized, double-blind, multi-centered clinical trial
Leung et al. Docosanol: a topical antiviral for herpes labialis
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
HK1180969B (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
JP2006327965A (ja) 皮膚外用剤とその適用
EP0078533B1 (en) Medicinal composition for treating skin disorders
WO2013077881A1 (en) Antiviral formulations
Altaei et al. The efficacy of topically applied silymarin in the treatment of herpes labialis ulcers
EP0706394A1 (en) Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
Committee on Drugs New Therapy for Severe Cystic Acne

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired